EHA-SWG Scientific Meeting on New Standards in Lymphoma Treatment and Immunotherapy in Adult and Elderly Patients

This EHA-SWG scientific meeting runs at the Radisson Hotel & Apartments in Gdańsk from 12 to 14 September 2026. It is intended for haematologists, haematology/oncology fellows and senior residents with clinical experience in lymphoma and immunotherapy. The now-published programme includes geriatric assessment and patient-reported-outcome workshops, sessions on ageing and lymphoma, new immunotherapeutic strategies, CAR T cells versus bispecific antibodies, infectious and non-infectious toxicities, access and reimbursement, and immunotherapy beyond lymphoma.

Abstract and clinical-case submission opened on 1 March and closed on 30 June 2026 at 23:59 CEST. Allocation notifications were scheduled for 15 July and withdrawals are permitted until 31 July. Accepted work may be assigned as an oral or poster presentation; presenters must register. Submissions required a title of no more than 300 characters, a 3,500-character body using Background, Aims, Methods, Results and Summary—Conclusion headings, obligatory references and no author limit. One simple JPEG, TIF or GIF image up to 500 KB was permitted.

Registration remains open. Early rates run through 31 July, regular rates through 31 August and late rates begin on 1 September. Fees include VAT, scientific and educational sessions, faculty networking during breaks, refreshments, the welcome reception and lunches on 13 and 14 September. EBAH accreditation is planned at one CME credit per accredited hour.